{
    "id": "0096d810-634e-4387-987b-489c513016a4",
    "indications": "Toremifene citrate tabletsÂ are an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.",
    "contraindications": "The dosage of toremifene citrate tablets is 60 mg, once daily, orally. Treatment is generally continued until disease progression is observed.",
    "adverseReactions": "Hypersensitivity to the drug ( 4.1 ) QT Prolongation, Hypokalemia, Hypomagnesemia ( 4.2 )",
    "ingredients": [
        {
            "name": "toremifene citrate",
            "code": "2498Y783QT"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "COPOVIDONE",
            "code": "D9C330MD8B"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "organization": "Rising Pharma Holdings, Inc.",
    "name": "toremifene citrate",
    "effectiveTime": "20250505"
}